FMR LLC 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 2,239,223 4.688% | -2,958,134 (-56.92%) | Filing |
| 2023-02-09 09:59 am Sale | 2023-02-09 | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 5,197,357 10.902% | -96,658 (-1.83%) | Filing |
| 2022-11-10 11:55 am Purchase | 2022-11-09 | 13G | DICE Therapeutics, Inc. DICE | FMR LLC | 5,294,015 11.107% | 5,294,015 (New Position) | Filing |